{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:33:45Z","timestamp":1787981625676,"version":"build-2784847793"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National natural science foundation key project","award":["81430096"],"award-info":[{"award-number":["81430096"]}]},{"name":"National natural science foundation key project","award":["81430096"],"award-info":[{"award-number":["81430096"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The abnormal metabolism of uric acid results in many disease such as chronic kidney disease, hyperuricemia, nephrolithiasis, gout, hypertension, vascular disease and so on. Serum uric acid levels are maintained by the balance between production and elimination. There are many factors that maintain the balance of serum uric acid. One of them is transporters which are responsible for the debouchment of uric acid within blood. The transport and excretion of uric acid is a complicated procedure which is related with various transporters such as OAT1, OAT3, OAT4, URAT1, GLUT9, BCRP, MRP4, NPT1, NTP4, and so on. In recent years, a large number of genome-wide association studies have shown that the single nucleotide polymorphisms of uric acid transporters were closely related to serum uric acid level. What\u2019s more, some mutations on these gene locus may also break the balance of serum uric acid. Here, the polymorphisms of uric acid transporters closely related with the serum uric acid balance were reviewed and discussed because of their important significance in clinical therapy for a precision medicine. The mechanism of metabolic diseases with gene variation may provide new strategy for the design and development of innovative drug to treat diseases with uric acid metabolic disturbance.<\/jats:p>","DOI":"10.1007\/s40620-018-0546-7","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T11:59:19Z","timestamp":1540987159000},"page":"177-187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["The effect of polymorphism of uric acid transporters on uric acid transport"],"prefix":"10.1093","volume":"32","author":[{"given":"Ze","family":"Wang","sequence":"first","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine, 300193, Tianjin, China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cui","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine, 300193, Tianjin, China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ci","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Drug Release Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research New Drug Evaluation Research, 300031, Tianjin, China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine, 300193, Tianjin, China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Sun","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine, 300193, Tianjin, China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhuo","family":"Li","sequence":"additional","affiliation":[{"name":"Tianjin Institute of Pharmaceutical Research, 300193, Tianjin, China 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine, 300193, Tianjin, China 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-6029","authenticated-orcid":false,"given":"Weidang","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Drug Release Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research New Drug Evaluation Research, 300031, Tianjin, China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulin","family":"Yi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Drug Release Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research New Drug Evaluation Research, 300031, Tianjin, China 2"},{"name":"Tianjin Institute of Pharmaceutical Research, 300193, Tianjin, China 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine, 300193, Tianjin, China 1"},{"name":"State Key Laboratory of Drug Release Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research New Drug Evaluation Research, 300031, Tianjin, China 2"},{"name":"Tianjin Institute of Pharmaceutical Research, 300193, Tianjin, China 3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"issue":"3","key":"2026012107103118600_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000355405 24454316","article-title":"Uric acid\u2014key ingredient in the recipe for cardiorenal metabolic syndrome","volume":"3","author":"Chaudhary","year":"2013","journal-title":"Cardiorenal Med"},{"issue":"5","key":"2026012107103118600_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.semnephrol.2011.08.009 22000652","article-title":"Uric ACID AND CHRONIC KIDNEY DISEASE: NEW UNDERSTANDING OF AN OLD PROBLem","volume":"31","author":"Kang","year":"2011","journal-title":"Semin Nephrol"},{"issue":"5","key":"2026012107103118600_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003 28748115","article-title":"Physiological functions and pathogenic potential of uric acid: a review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J Adv Res"},{"issue":"11","key":"2026012107103118600_CR4","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/rheumatology\/keq204 20627967","article-title":"Uric acid and evolution","volume":"49","author":"\u00c1lvarez-Lario","year":"2010","journal-title":"Rheumatology"},{"issue":"1","key":"2026012107103118600_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.autrev.2012.07.024 22884557","article-title":"Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets","volume":"12","author":"Punzi","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"10","key":"2026012107103118600_CR6","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s12272-014-0413-6","article-title":"Anti-hyperuricemic and nephroprotective effects of Rhizoma Dioscoreae septemlobae extracts and its main component dioscin via regulation of mOAT1, mURAT1 and mOCT2 in hypertensive mice","volume":"37","author":"Su","year":"2014","journal-title":"Arch Pharmacal Res"},{"issue":"9711","key":"2026012107103118600_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/s0140-6736(09)60883-7 19692116","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Gout Lancet"},{"key":"2026012107103118600_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ncomms1756 22473008","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"issue":"1","key":"2026012107103118600_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/1471-2369-14-164 23895142","article-title":"The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality","volume":"14","author":"Gustafsson","year":"2013","journal-title":"BMC Nephrol"},{"issue":"3","key":"2026012107103118600_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11926-015-0495-2 25740704","article-title":"Hyperuricemia, gout, and cardiovascular disease: an update","volume":"17","author":"Abeles","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"2026012107103118600_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ejim.2015.04.005 25898779","article-title":"A brief history of uric acid: from gout to cardiovascular risk factor","volume":"26","author":"Galassi","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2026012107103118600_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4081\/aiua.2016.1.38 27072174","article-title":"Herbal medicines for urinary stone treatment. A systematic review","volume":"88","author":"Monti","year":"2016","journal-title":"Archivio Italiano di Urologia e Andrologia"},{"issue":"1","key":"2026012107103118600_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ucl.2012.09.011","article-title":"Diet and alternative therapies in the management of stone disease","volume":"40","author":"Penniston","year":"2013","journal-title":"Urol Clin"},{"issue":"2","key":"2026012107103118600_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s11926-013-0400-9 24357445","article-title":"The crystallization of monosodium urate","volume":"16","author":"Martillo","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"2026012107103118600_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109 26316329","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"2026012107103118600_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010 22841915","article-title":"Drug transport by organic anion transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacol Ther"},{"issue":"6","key":"2026012107103118600_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/circgenetics.109.934455 20884846","article-title":"Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors","volume":"3","author":"Yang","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"2026012107103118600_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MNH.0b013e32835ddad2 23318701","article-title":"The kidney in hyperuricemia and gout","volume":"22","author":"Mount","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"2026012107103118600_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd4461 25475361","article-title":"What do drug transporters really do?","volume":"14","author":"Nigam","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2026012107103118600_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11926-012-0240-z 22359229","article-title":"Regulation of uric acid excretion by the kidney","volume":"14","author":"Lipkowitz","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"2026012107103118600_CR21","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1093\/molbev\/msw116 27352852","article-title":"Coevolution of URAT1 and uricase during primate evolution: implications for serum urate homeostasis and gout","volume":"33","author":"Tan","year":"2016","journal-title":"Mol Biol Evol"},{"issue":"6","key":"2026012107103118600_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.dmpk.2016.07.004 27720648","article-title":"Common variant of PDZ domain containing 1 (PDZK1) gene is associated with gout susceptibility: a replication study and meta-analysis in Japanese population","volume":"31","author":"Higashino","year":"2016","journal-title":"Drug Metab Pharmacokinet"},{"issue":"8","key":"2026012107103118600_CR23","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00467-012-2174-0 22527535","article-title":"Acute kidney injury in two children caused by renal hypouricaemia type 2","volume":"27","author":"Stiburkova","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2026012107103118600_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jare.2017.05.001 28748122","article-title":"Asymptomatic hyperuricemia and chronic kidney disease: narrative review of a treatment controversial","volume":"8","author":"Eleftheriadis","year":"2017","journal-title":"J Adv Res"},{"issue":"2","key":"2026012107103118600_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/art.24164 19177541","article-title":"Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study","volume":"61","author":"Chen","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2026012107103118600_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/rheumatology\/kel205 16837472","article-title":"Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout","volume":"46","author":"V\u00e1zquez-Mellado","year":"2007","journal-title":"Rheumatology"},{"key":"2026012107103118600_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cca.2016.10.025 27780716","article-title":"A novel compound heterozygous mutation in the SLC22A12 (URAT1) gene in a Japanese patient associated with renal hypouricemia","volume":"463","author":"Fujita","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2026012107103118600_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gene.2012.09.115 23043931","article-title":"Novel URAT1 mutations caused acute renal failure after exercise in two Chinese families with renal hypouricemia","volume":"512","author":"Li","year":"2013","journal-title":"Gene"},{"issue":"1","key":"2026012107103118600_CR29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/art.21499 16385546","article-title":"Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population","volume":"54","author":"Graessler","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2026012107103118600_CR30","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2337\/dc09-0288 19549729","article-title":"Association between serum uric acid and development of type 2 diabetes","volume":"32","author":"Kodama","year":"2009","journal-title":"Diabetes Care"},{"issue":"6","key":"2026012107103118600_CR31","doi-asserted-by":"publisher","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504 19503597","article-title":"Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations","volume":"5","author":"Kolz","year":"2009","journal-title":"PLoS Genet"},{"issue":"8","key":"2026012107103118600_CR32","first-page":"13911","article-title":"Genetic polymorphisms in the PDZK1 gene and susceptibility to gout in male Han Chinese: a casecontrol study","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2026012107103118600_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/annrheumdis-2014-205877 25187157","article-title":"Twenty-eight loci that influence serum urate levels: analysis of association with gout","volume":"75","author":"Phipps-Green","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2026012107103118600_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1681\/asn.2006040415 17229912","article-title":"Human renal organic anion transporter 4 operates as an asymmetric urate transporter","volume":"18","author":"Hagos","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2026012107103118600_CR35","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1681\/asn.2005030306 16236806","article-title":"Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins","volume":"16","author":"Miyazaki","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2026012107103118600_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2133\/dmpk.dmpk-13-nt-070 24025986","article-title":"A common variant of organic anion transporter 4 (OAT4\/SLC22A11) gene is associated with renal underexcretion type gout","volume":"29","author":"Sakiyama","year":"2014","journal-title":"Drug Metab Pharmacokinet"},{"issue":"10","key":"2026012107103118600_CR37","doi-asserted-by":"publisher","first-page":"e108852","DOI":"10.1371\/journal.pone.0108852 25286413","article-title":"Expression, purification, and structural insights for the human uric acid transporter, GLUT9, using the Xenopus laevis oocytes system","volume":"9","author":"Cl\u00e9men\u00e7on","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2026012107103118600_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1681\/asn.2009040406 19926891","article-title":"Homozygous SLC2A9 mutations cause severe renal hypouricemia","volume":"21","author":"Dinour","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2026012107103118600_CR39","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/15257770.2011.623685 22132964","article-title":"Pathogenic GLUT9 mutations causing renal hypouricemia type 2 (RHUC2)","volume":"30","author":"Kawamura","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"4","key":"2026012107103118600_CR40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng.107 18327256","article-title":"SLC2A9 influences uric acid concentrations with pronounced sex-specific effects","volume":"40","author":"D\u00f6ring","year":"2008","journal-title":"Nat Genet"},{"issue":"11","key":"2026012107103118600_CR41","doi-asserted-by":"publisher","first-page":"e1000246","DOI":"10.1371\/journal.pgen.1000246 18989453","article-title":"Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog","volume":"4","author":"Bannasch","year":"2008","journal-title":"PLoS Genet"},{"issue":"6","key":"2026012107103118600_CR42","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ajhg.2008.11.001 19026395","article-title":"Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia","volume":"83","author":"Matsuo","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2026012107103118600_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000318943 20714133","article-title":"Association of four genetic loci with uric acid levels and reduced renal function: the J-SHIPP Suita study","volume":"32","author":"Tabara","year":"2010","journal-title":"Am J Nephrol"},{"issue":"9654","key":"2026012107103118600_CR44","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/s0140-6736(08)61343-4 18834626","article-title":"Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study","volume":"372","author":"Dehghan","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"2026012107103118600_CR45","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ng.531 20139978","article-title":"Genome-wide association study of hematological and biochemical traits in a Japanese population","volume":"42","author":"Kamatani","year":"2010","journal-title":"Nat Genet"},{"issue":"3","key":"2026012107103118600_CR46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/ckj\/sfw010 27274832","article-title":"Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling","volume":"9","author":"Bhatnagar","year":"2016","journal-title":"Clin Kidney J"},{"issue":"1","key":"2026012107103118600_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10157-013-0806-8 23584883","article-title":"Uric acid transporter ABCG2 is increased in the intestine of the 5\/6 nephrectomy rat model of chronic kidney disease","volume":"18","author":"Yano","year":"2014","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"2026012107103118600_CR48","doi-asserted-by":"publisher","first-page":"e30456","DOI":"10.1371\/journal.pone.0030456 22348008","article-title":"Extra-renal elimination of uric acid via intestinal efflux transporter BCRP\/ABCG2","volume":"7","author":"Hosomi","year":"2012","journal-title":"PLoS One"},{"issue":"13","key":"2026012107103118600_CR49","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.ejca.2011.03.032 21531129","article-title":"Prognostic value of the multidrug resistance transporter ABCG2 gene polymorphisms in Chinese patients with de novo acute leukaemia","volume":"47","author":"Wang","year":"2011","journal-title":"Eur J Cancer"},{"issue":"2","key":"2026012107103118600_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1469-1809.2011.00698.x 22229870","article-title":"Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia","volume":"76","author":"Karns","year":"2012","journal-title":"Ann Hum Genet"},{"issue":"8","key":"2026012107103118600_CR51","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/keq096 20421215","article-title":"The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people","volume":"49","author":"Yamagishi","year":"2010","journal-title":"Rheumatology"},{"issue":"25","key":"2026012107103118600_CR52","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.0901249106 19506252","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout","volume":"106","author":"Woodward","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2026012107103118600_CR53","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/1756-185x.12519 25639607","article-title":"Association between ABCG2 Q141K polymorphism and gout risk affected by ethnicity and gender: a systematic review and meta-analysis","volume":"18","author":"Dong","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"2026012107103118600_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jfma.2015.12.002 26792383","article-title":"Association of ABCG2 rs2231142-A allele and serum uric acid levels in male and obese individuals in a Han Taiwanese population","volume":"116","author":"Cheng","year":"2017","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"2026012107103118600_CR55","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.2337\/dc08-0349 18487473","article-title":"Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI","volume":"31","author":"Brandst\u00e4tter","year":"2008","journal-title":"Diabetes Care"},{"issue":"2","key":"2026012107103118600_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/03009742.2011.637952 22420403","article-title":"Gender-dependent associations of uric acid levels with a polymorphism in SLC2A9 in Han Chinese patients","volume":"41","author":"Hu","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"2026012107103118600_CR57","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1038\/srep05227 24909660","article-title":"Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors","volume":"4","author":"Nakayama","year":"2014","journal-title":"Sci Rep"},{"issue":"4\u20136","key":"2026012107103118600_CR58","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/15257770.2013.866679 24940678","article-title":"ABCG2 dysfunction increases the risk of renal overload hyperuricemia","volume":"33","author":"Matsuo","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"1","key":"2026012107103118600_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/bse0500179 21967058","article-title":"Mammalian multidrug-resistance proteins (MRPs)","volume":"50","author":"Slot","year":"2011","journal-title":"Essays Biochem"},{"issue":"6","key":"2026012107103118600_CR60","doi-asserted-by":"publisher","first-page":"R2024","DOI":"10.1152\/ajpregu.90471.2008 18945957","article-title":"Avian renal proximal tubule epithelium urate secretion is mediated by Mrp4","volume":"295","author":"Bataille","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"10","key":"2026012107103118600_CR61","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.bbadis.2013.05.002 23665398","article-title":"Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP)","volume":"1832","author":"Dankers","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"7571","key":"2026012107103118600_CR62","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Genomes Project","year":"2015","journal-title":"Nature"},{"key":"2026012107103118600_CR63","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bcp.2016.09.016 27659809","article-title":"Polymorphic variants of MRP4\/ABCC4 differentially modulate the transport of methylated arsenic metabolites and physiological organic anions","volume":"120","author":"Banerjee","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"2026012107103118600_CR64","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/art.40110 28371506","article-title":"Population-specific resequencing associates the ATP-binding cassette subfamily C member 4 gene with gout in New Zealand M\u0101ori and Pacific Men","volume":"69","author":"Tanner","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"34","key":"2026012107103118600_CR65","doi-asserted-by":"publisher","first-page":"26107","DOI":"10.1074\/jbc.m110.122721 20566650","article-title":"Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter","volume":"285","author":"Iharada","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"2026012107103118600_CR66","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/art.38884 25252215","article-title":"NPT1\/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout","volume":"67","author":"Chiba","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"2026012107103118600_CR67","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/ard.2008.106856 19556210","article-title":"Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout","volume":"69","author":"Urano","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2026012107103118600_CR68","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/ar3816 22541845","article-title":"The renal urate transporter SLC17A1 locus: confirmation of association with gout","volume":"14","author":"Hollis-Moffatt","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"45","key":"2026012107103118600_CR69","doi-asserted-by":"publisher","first-page":"35123","DOI":"10.1074\/jbc.m110.121301 20810651","article-title":"Human sodium phosphate transporter 4 (hNPT4\/SLC17A3) as a common renal secretory pathway for drugs and urate","volume":"285","author":"Jutabha","year":"2010","journal-title":"J Biol Chem"},{"issue":"2","key":"2026012107103118600_CR70","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1254\/jphs.10228sc 21282933","article-title":"Functional analysis of human sodium-phosphate transporter 4 (NPT4\/SLC17A3) polymorphisms","volume":"115","author":"Jutabha","year":"2011","journal-title":"J Pharmacol Sci"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0546-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-0546-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/32\/2\/177\/66505266\/joneph_32_2_546.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0546-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/32\/2\/177\/66505266\/joneph_32_2_546.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:10:47Z","timestamp":1768997447000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/2\/177\/8328148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,10,31]]},"published-print":{"date-parts":[[2019,4,12]]}},"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0546-7","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,1]]},"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}